PFKL and cardiac hypertrophy: Thus, to assess whether KLF7 can trigger pathological cardiac hypertrophy by balancing the expression of PFKL and ACADL in vivo, we generated transgenic mice (TG) in a cardiac myocyte-specific manner (Fig. 5a).